Understanding IVF and Artificial Fertilisation

Infertility is a complex medical condition defined as the inability to achieve a clinical pregnancy after 12 months of regular, unprotected sexual intercourse. For women over the age of 35, this window is often shortened to six months due to the natural decline in ovarian reserve. While the diagnosis can feel isolating, it is a shared reality for approximately one in six couples globally. Fortunately, the field of reproductive medicine has evolved rapidly, offering sophisticated solutions through Assisted Reproductive Technology (ART).

Medical centers of excellence, such as Liv Hospital, emphasize that the path to parenthood begins not with a procedure, but with a precise diagnosis. Understanding the underlying etiology of infertility is the critical first step in determining whether In Vitro Fertilization (IVF) or other forms of artificial fertilisation are the appropriate course of action.

The Spectrum of Infertility Causes

Infertility is rarely the result of a single factor; it is often a multifactorial issue involving male factors, female factors, or a combination of both. To treat the condition effectively, physicians must first categorize the root cause.

1. Female Factor Infertility Female infertility accounts for approximately one-third of all cases and can stem from various physiological disruptions:

• Ovulatory Disorders: The most common cause of female infertility is the failure to ovulate regularly. Conditions such as Polycystic Ovary Syndrome (PCOS) or hypothalamic dysfunction can disrupt the hormonal signals (FSH and LH) required to release a mature egg.
• Tubal Factor: The fallopian tubes are the site of fertilization in natural conception. Blockages caused by pelvic inflammatory disease (PID), previous surgeries, or infection can prevent the sperm from meeting the egg or the embryo from reaching the uterus.

• Endometriosis: This condition involves the growth of endometrial-like tissue outside the uterus. It can cause inflammation, scarring, and anatomical distortion, all of which hinder conception.
• Uterine Factors: Structural abnormalities such as fibroids, polyps, or a congenital uterine septum can interfere with the implantation of the embryo.

2. Male Factor Infertility Contributing to roughly another third of cases, male factor infertility is diagnosed through the evaluation of sperm parameters. Issues may range from oligospermia (low sperm count) and asthenospermia (poor motility) to teratospermia (abnormal morphology). In some cases, there may be a complete absence of sperm in the ejaculate (azoospermia), requiring surgical retrieval methods.

3. Unexplained Infertility In approximately 15-30% of couples, standard diagnostic tests yield normal results. This diagnosis of exclusion suggests that there are subtle defects in fertilization or embryo quality that current technology cannot easily detect prior to an IVF cycle.

The Comprehensive Evaluation Process

Before a treatment plan is designed, a couple undergoes a systematic fertility workup. This diagnostic phase is designed to assess the reproductive potential of both partners.

Hormonal Profiling and Ovarian Reserve Testing For the female partner, blood tests are conducted early in the menstrual cycle (Day 2 or 3) to measure baseline hormone levels. Key markers include Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), and Estradiol.

Crucially, the evaluation of ovarian reserve—the remaining supply of eggs—is performed using Anti-Müllerian Hormone (AMH) testing and an antral follicle count (AFC) via transvaginal ultrasound. These metrics do not predict the ability to conceive naturally but are vital for predicting how the ovaries will respond to the stimulation medications used in IVF.

Anatomical Assessment: Hysterosalpingography (HSG) To ensure the structural integrity of the reproductive tract, an HSG is often performed. This fluoroscopic procedure involves injecting a contrast dye into the uterus. X-ray imaging then tracks the dye as it fills the uterine cavity and spills out of the fallopian tubes. This test confirms tubal patency and outlines the shape of the uterine cavity, ruling out major physical barriers to pregnancy.

Semen Analysis The cornerstone of the male evaluation is the semen analysis. A laboratory specialist assesses the volume, concentration, motility, and morphology of the sperm. Advanced testing, such as sperm DNA fragmentation assays, may be recommended if recurrent pregnancy loss or implantation failure is a concern.

From Diagnosis to Treatment Strategy

The synthesis of these diagnostic results informs the clinical pathway. A detailed understanding of IVF Artificial Fertilisation Causes and Evaluation allows the medical team to select the most effective protocol. For instance, severe male factor infertility often necessitates Intra-Cytoplasmic Sperm Injection (ICSI), where a single sperm is injected directly into an egg. Conversely, blocked tubes make standard IVF the only viable option, as it bypasses the tubes entirely.

In cases of unexplained infertility, the evaluation may lead to a trial of Intrauterine Insemination (IUI) before progressing to IVF. However, for older patients with diminished ovarian reserve, moving directly to IVF is often the medically recommended route to maximize the chances of success within a limited biological window.

A Holistic Approach to Fertility

While the diagnostic evaluation focuses heavily on biological markers and anatomical structures, the patient’s general health provides the essential context for these medical interventions. Lifestyle factors—including nutrition, weight management, and stress levels—can significantly influence hormonal balance and gamete quality. Physicians increasingly advocate for an integrated approach where clinical excellence is supported by a healthy lifestyle. For those seeking resources on maintaining wellness and balance during the rigors of medical treatment, live and feel offers valuable insights into living a vibrant, health-conscious life.